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Background: Extensor synergy is often observed in the paretic leg of stroke patients. Extensor synergy consists of an
abnormal stereotyped co-activation of the leg extensors as patients attempt to move. As a component of this synergy,
the simultaneous activation of knee and ankle extensors in the paretic leg during stance often affects gait pattern after
stroke. The mechanisms involved in extensor synergy are still unclear. The first objective of this study is to compare the
co-activation of knee and ankle extensors during the stance phase of gait between stroke and healthy individuals. The
second objective is to explore whether this co-activation is related to changes in heteronymous spinal modulations
between quadriceps and soleus muscles on the paretic side in post-stroke individuals.
Methods: Thirteen stroke patients and ten healthy individuals participated in gait and heteronymous spinal modulation
evaluations. Co-activation was measured using peak EMG activation intervals (PAI) and co-activation amplitude
indexes (CAI) between knee and ankle extensors during the stance phase of gait in both groups. The evaluation
of heteronymous spinal modulations was performed on the paretic leg in stroke participants and on one leg in
healthy participants. This evaluation involved assessing the early facilitation and later inhibition of soleus voluntary
EMG induced by femoral nerve stimulation.
Results: All PAI were lower and most CAI were higher on the paretic side of stroke participants compared with
the co-activation indexes among control participants. CAI and PAI were moderately correlated with increased
heteronymous facilitation of soleus on the paretic side in stroke individuals.
Conclusions: Increased co-activation of knee and ankle extensors during gait is related to changes in intersegmental
facilitative pathways linking quadriceps to soleus on the paretic side in stroke individuals. Malfunction of intersegmental
pathways could contribute to abnormal timing of leg extensors during the stance phase of gait in hemiparetic
individuals.
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Following stroke, impaired coordination is frequently
observed and manifests by the incapacity to activate
muscles selectively [1]. This lack of voluntary control
produces abnormal coupling of joint movements on the
paretic side that can hamper motor task performance* Correspondence: joseph.omer.dyer@umontreal.ca
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unless otherwise stated.[1-3]. Altered motor coordination in the paretic leg among
stroke patients is associated with functional deficits [4]. As
a result of this lack of coordination, these patients often
produce stereotypical co-activation of several muscles on
the paretic side as they voluntarily attempt to move [1,5].
These co-activations, which are commonly referred to
as abnormal synergies, are defined as the simultaneous
recruitment of muscles at multiple joints resulting in a
stereotypical pattern of movement [6]. In the paretic leg of
stroke patients, prevalent extensor synergy consisting
of the co-contraction (i.e., co-activation) of the majorityd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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most of the stance phase of gait [7,8]. This co-activation
can be observed in EMG tracings showing the simultan-
eous activation of leg extensors during stance [6]. In the
present study, the term “co-activation” will be used to
describe the simultaneous EMG activity in knee and
ankle extensor muscles [9]. This co-activation is a key
component of extensor synergy [7] since it can produce
abnormal coupling of knee and ankle extension, often
resulting in an altered gait pattern after stroke [7,10].
Since knee and ankle extensors are both anti-gravity
muscles with out-of-phase activation during healthy
gait, their abnormal co-activation could contribute to
hemiparetic gait disabilities. The quadriceps muscle
normally reaches its peak activation during the early
stance phase in order to support body weight [11]. In
turn, calf muscles demonstrate maximal activity during
the late stance phase in order to control ankle dorsiflexion
and produce push off [12]. In hemiparetic gait, prolonged
activation of the quadriceps at the end of the stance phase
[8,13] may impede knee flexion in preparation for the
swing phase. Premature activation of ankle extensors early
in the stance phase [14,15] could hamper body weight
support upon initial foot contact [7]. These changes are
consistent with abnormal co-activation of leg extensors on
the paretic side during the stance phase of gait [14,16].
Although the co-activation of leg extensors has been
widely described in clinical literature, few studies have
quantified its extent in the paretic leg during gait. The
paucity of studies assessing muscular co-activation via
EMG approaches may stem from limitations related to
the normalization of EMG signals [17] and the deter-
mination of the timing of muscular activation [18],
variables which allow inter-subject comparisons to be
made. Analyses of EMG activity by factorization procedures
have been used to objectively identify shared patterns of
activation among different muscle groups in the paretic
lower limb during gait [19,20]. Through the use of a
factorization procedure, it has been shown that the number
of EMG modules required to describe muscle activation
patterns in the paretic leg correlates with walking per-
formance measures in post-stroke individuals [19].
Furthermore, the underlying mechanisms of leg exten-
sor co-activation after stroke are not fully understood.
Supraspinal and spinal mechanisms may both contribute
to motor deficits in the paretic leg [21-23]. Spinal inter-
neuronal systems are basic sensorimotor mechanisms
that can integrate influences from sensory and descen-
ding pathways to modulate the activity of motoneurones
(MNs) [9,21]. Intersegmental or propriospinal pathways
can regulate the activity of muscles acting at different joints
[21,24]. In humans, these pathways are assessed with
electrophysiological methods, whereby conditioning stimu-
lation is used to modulate the activity of a heteronymousmuscle [25-27]. For example, intersegmental excitatory
and inhibitory pathways linking quadriceps (Quads) to
soleus (Sol) can be assessed by measuring the effects of
femoral nerve (FN) stimulation on Sol activity [9,21].
More precisely, FN stimulation induces early, short-term
facilitation and later longer-lasting inhibition of both Sol
H reflex and voluntary EMG, which have been attributed
to projections from Quads to Sol group excitation and
recurrent inhibition, respectively [28,29]. An increase in
early heteronymous facilitation and a decrease in later
inhibition of Sol activity after FN stimulation have been
found in stroke subjects [21]. Moreover, based on the
results of this study, increased facilitation was correlated
with level of motor coordination of the paretic leg [21].
This raises the question of whether co-activation of knee
and ankle extensors in the paretic leg during gait is related
to transmission changes in intersegmental pathways
linking Quads to Sol. This study aims to (1) compare co-
activation of knee and ankle extensors during gait between
stroke and healthy individuals, (2) assess whether this
co-activation is related to clinical measures of motor
deficits after stroke, and (3) determine whether it is
related to changes in heteronymous modulations of Sol
voluntary EMG after FN stimulation in the paretic leg.
Methods
Participants
Thirteen stroke patients (mean ± SD: 51 ± 15 years; 5
females; 8 males) and ten healthy individuals (44 ± 13 years;
2 females; 8 males) of similar age (Mann-Whitney U:
P = 0.24) participated in the study. The mean weight of
the stroke participants (69.3 ± 9.2 kg) was not significantly
different (P = 0.19) from that of the control participants
(76.2 ± 11.9 kg). The mean height of the stroke partici-
pants (1.65 ± 0.07 m) was less (P = 0.02) than the mean
height of the healthy participants (1.72 ± 0.06 m). All
participants gave their written informed consent to par-
ticipate in the study, which had been approved by the
internal ethics committee for institutions affiliated with
the Centre for Interdisciplinary Research in Rehabilitation
of Greater Montreal (CRIR). Stroke participants were
recruited based on the following criteria: a single cerebro-
vascular accident involving the motor cortex, internal
capsulae or sub-cortical areas as documented by brain
imagery findings and resulting in motor deficits of abrupt
onset affecting the contralateral leg. All stroke participants
were able to walk independently and continuously for at
least 10 m, without a walking device (e.g., cane, orthosis)
and had an activity tolerance of at least 2 hours including
rest periods. Moreover, all stroke patients were able to
perform the experimental task, which was to press on a
fixed pedal with the forefoot in order to achieve and
maintain a steady isometric calf muscle contraction for at
least 5 s. All participants tested had detectable patellar
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jects were excluded if they were on antispastic, anxiolytic
or antidepressant medication at the time of the study, or if
they had comprehensive aphasia, hemispatial neglect or a
passive range of motion limitation at the paretic leg
that could interfere with the experimental positioning.
Moreover, participants did not have stimulators (e.g.,
pacemakers) or metallic implants and did not suffer from
orthopaedic or neurological disorders other than stroke.
Table 1 summarizes the demographic data for the stroke
participants together with scores for clinical measure-
ments of coordination, spasticity and motor recovery of
the lower limb and gait speed, which were assessed as
described below. With the exception of one participant
(stroke individual # 13 in Table 1), all subjects had partici-
pated in a previous study at our laboratory [9]. Subjects
were completely reassessed in terms of the needs of this
study following a minimum delay of one week from
completing their participation in the previous study [9].
Clinical assessment
All clinical measurements were performed prior to any
experimental procedures as described in the previous
study [9]. Degree of spasticity of the paretic leg was
measured using a reliable composite spasticity index
(CSI) designed for stroke patients. Practical consider-
ations on the use of a CSI are described by Levin and
Hui-Chan (1993). Briefly, the CSI is a 16-point scale
measuring the amplitude of an Achilles tendon tap (4
points), resistance to full-range passive ankle dorsiflexion at
moderate speed (8 points), and duration of the clonus at
the ankle (4 points). Interval values of 1-5, 6-9, 10-12 and
13-16 correspond to absent, mild, moderate and severeTable 1 Demographic and clinical data for stroke participants




1 57/M L 79
2 24/M L 99
3 43/F R 38
4 59/M L 81
5 45/M R 79
6 72/M L 48
7 59/F L 57
8 43/F R 90
9 72/M L 96
10 28/F R 108
11 45/F L 96
12 54/M R 149
13 68/M L 120
LEMOCOT: Lower Extremity Motor Coordination Test; CMSA at Foot: Chedoke-McMaspasticity, respectively [30]. Motor coordination of the par-
etic leg was measured using the Lower Extremity Motor
Coordination Test (LEMOCOT), validated among stroke
individuals [4]. During this test, participants were seated
and instructed to touch two standardized targets placed
30 cm apart on the floor with their foot, as fast and as
accurately as possible during a 20-second period. The
LEMOCOT score was calculated as the number of times
the subject touched the two targets. Motor impairment
was measured using the reliable Chedoke-McMaster
Stroke Assessment (CMSA) subscale at the foot [31]. This
subscale ranges from 1 (no residual motor function) to
7 (no residual motor impairment) and is based on
Brunnstrom’s stages of motor recovery of the lower limb
after stroke [5]. A self-selected comfortable walking speed
over a 5-m distance without technical assistance (cane,
walker or orthosis) was used as a standard and reliable
method to measure gait performance in stroke participants
[32,33]. Average walking speed was measured during three
trials. This clinical evaluation was followed by the experi-
mental session, which was comprised of two assessments
performed in random order that same day: 1) measure-
ment of the co-activation of knee and ankle extensors
during gait; and 2) electrophysiological evaluation of
the heteronymous modulation of Sol by FN stimulation.
Participants were not aware of the specific significance
of the gait and electrophysiological assessments.
Gait assessment
Experimental set-up and procedures
Three footswitches acting as force sensing resistors were
placed under the shoe of each foot, at the heel, mid-sole
and toes. ON and OFF signals from these switches wereCMSA at
foot (/7)
LEMOCOT (# of times
participant hit target)
CSI (/16) Gait speed
(m/s)
5 35 10 0.8
3 7 13 0.5
6 26 6 1.0
7 23 5 1.0
7 24 8 1.1
5 22 6 1.0
7 21 7 0.7
3 22 8 1.0
4 14 7 0.5
4 13 12 0.9
7 52 5 1.3
2 1 7 0.5
3 13 8 0.6
ster Stroke Assessment at the foot; CSI: Composite Spasticity Index.
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of the lower limbs. EMG activities of Sol, gastrocnemius
lateralis (GL), rectus femoris (RF) and vastus lateralis (VL)
were simultaneously recorded on both sides. The skin
was first rubbed with alcohol to reduce its impedance.
Disposable, self-adhesive, Ag/Ag-Cl surface electrodes
(Ambu® Blue Sensor SP) were fixed in a bipolar configur-
ation (at a 2-cm interelectrode distance with an 8 mm
space between each recording areas) over the muscle
bellies, based on SENIAM recommendations [34]. EMG
signals were tested for crosstalk by performing standard
muscle testing, rapid alternating movements and using a
minimal interelectrode distance. EMG signals were col-
lected during the gait assessment using a telemetric system
(Telemyo 900, NORAXON Telemyo System, Scottsdale,
AZ), relayed to a battery-powered amplifier (2000×) and
transmitted to a receiver interfaced with a PC card. Signals
were further digitalized at a sampling rate of 1200 Hz
(bandwidth of 10 to 500 Hz) using software built on a
LabVIEW 5.0 platform (National Instruments) and stored
on a computer for subsequent analysis.
Stroke and healthy participants were instructed to
walk on a 10-m walkway at a self-selected comfortable
speed without technical assistance. Healthy participants
were also asked to walk at a slower speed in order to
match the self-selected comfortable speed of the stroke
participants [35]. For each speed tested, participants were
asked to complete three gait trials, with a minimum,
2-min rest period after each trial. Time was recorded
for each trial using a digital stopwatch over a 5-m
distance in the middle of the walkway. In this study, the
comfortable self-selected gait speed of the stroke partici-
pants (mean ± SD: 0.85 ± 0.26 m/s) was lower (P <0.001)
than the comfortable speed (1.22 ± 0.14 m/s) of the
healthy participants but not different (Mann-Whitney U:
P =0.62) from the self-selected slow speed (0.93 ± 0.14 m/s)
of the healthy participants. Speed has been previously
shown to influence muscular activation patterns and
co-activation levels [36-38]. Therefore, all gait assessments
and comparisons were performed at a comfortable speed
in stroke participants and at a slow speed in healthy
participants. At these speeds, the cadence of stroke partic-
ipants (95 ± 18 steps/min.) was not different (P = 0.73)
from the cadence of healthy participants (93 ± 10 steps/
min.). Moreover, the step length on the paretic side
(0.59 m ±0.13 m) was not different (P = 0.71) from the
step length on the side evaluated in healthy participants
(0.61 m ±0.05 m).
Gait assessment data analysis
All data analyses were performed off- line. Both sides were
assessed in stroke participants and the side of control
participants was randomly chosen. Foot switches and
EMG signals were analyzed during each trial in the middleof the walkway, i.e., 2 m after the start line and 2 m before
the finish line to avoid acceleration and deceleration bias.
Three gait cycles were determined for each leg using the
moment of heel strike on both sides. Each gait cycle
selected was further subdivided into swing phase, stance
phase, first (DS1) and second (DS2) double-support phases
and single-support phase (SS) for each leg according to
switch signals on both sides. Prior to analysis, all digital
EMG signals were first filtered using a zero-phase shift
fourth-order digital Butterworth band-pass filter (0-125 Hz)
in order to reduce high frequency noise. For each gait cycle,
digital EMG signals were full-wave rectified to obtain linear
envelopes and were normalized to 100% of the entire gait
cycle duration.
For each normalized gait cycle, the peak EMG activity
achieved in each muscle was determined as the maximal
EMG that can be measured in that muscle within a time
window corresponding to 5% of the gait cycle during the
stance phase. The timing of this peak during the gait
cycle was expressed as a percentage of the length of the
gait cycle. Two co-activation indexes were measured
during the stance phase of each gait cycle between ankle
and knee extensors: 1) peak activation intervals (PIA)
related to the timing of co-activation, and 2) co-activation
amplitude indexes (CAI) measuring relative EMG ampli-
tudes of co-activation. PAI was determined by the time
interval (expressed as a percentage of the length of the
gait cycle) between peak activation of ankle extensors
(Sol or GL) and knee extensors (VL or RF). For example,
the PAISol-VL represents the time interval between peak
activation of Sol and VL during the stance phase. PAI has
advantages over other measures since it is not dependent
on the determination of EMG onset following an arbitrary
threshold and it does not rely on unpredictable shapes of
the estimated activation patterns [18]. Instead, it is based
on the detection of peak muscular activation, which is
easily determined and quantified objectively.
CAI was determined by mean EMG activation in a
given muscle, expressed as a percentage of its maximal
EMG during the stance phase, within the peak activation
time window of a reference muscle at another joint. For
example, CAISol/Vlmax represents the mean level of Sol
EMG during peak activation of VL. As for the PAI meas-
ure, CAI does not rely on the detection of EMG onset
after an arbitrary threshold. Furthermore, CAI values
were expressed as a percentage of maximal EMG activity
of the muscle assessed during the gait cycle. This method
of normalization was found to be more reliable for
assessing levels of EMG activation during gait [39,40]
and more appropriate for inter-group comparisons
[41,42] than other normalization methods based on
maximal contractions produced with a dynamometer
[17,41]. PAI and CAI presented in this study are the
mean values of 9 gait cycles recorded during 3 gait trials.
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The assessment of the heteronymous modulation presented
in this section was performed as described in the previous
study [9].
Experimental set-up and instrumentation
Participants were seated comfortably in an adjustable
reclining armchair with the foot strapped to a fixed
pedal. The paretic leg was tested in stroke patients and
the side tested in control individuals was randomly
selected. The leg tested was positioned with the hip
flexed (80°), the knee slightly flexed (10°) and the ankle
slightly plantarflexed (110°) (see Figure 1). The FN was
stimulated with a 1-ms duration monophasic rectangular
pulse (Grass S88 stimulator) delivered by a cathode (2-cm-
diameter half-ball) at the femoral triangle and an anode
(11.5 cm × 8 cm) placed at the postero-lateral aspect of the
buttock. The intensity of the stimulation was progressively
increased to determine the thresholds of the H reflex and
of the M response (MT) for VL. The intensity was then
maintained at 2 × MT for the remainder of the experiment.
EMG activities of Sol and VL were recorded (Grass, model
12 acquisition system) using bipolar surface electrodes
(Beckmann, Ag-AgCl; 9 mm diameter) placed 2 cm apart
(center-to-center). The recording electrodes were secured
over the belly of VL (on the distal third of the antero-
lateral aspect of the thigh) and Sol (on the distal third
of the postero-lateral aspect of the leg, just below the
lateral gastrocnemius). EMG signals were first amplified
(5000×), then filtered (30–1000 Hz) (Grass, model 12
A 5) and finally, digitalized at a sampling rate of 5 kHz.
EMG signals were displayed on an oscilloscope and
stored on computer for off-line analysis [9].Figure 1 Participants were seated with the hip flexed (80°), the knee sli
foot on a fixed platform on the tested side. Participants produced isometr
recorded. The FN was stimulated with a cathode at the femoral triangle and aExperimental protocol for modulation assessment
Participants were instructed to press on the fixed platform
with the forefoot in order to produce isometric plantarflex-
ion contractions. The level of EMG activity of Sol during
maximal isometric voluntary contractions during 5 s of
plantarflexion (EMGmax) was first determined for each
participant (mean of three trials). All participants then had
to produce sustained isometric plantarflexion contractions
to activate Sol at 30% of its EMGmax. Throughout the
experiment, an analogue voltmeter facing the participant
displayed visual feedback on the level of voluntary activity
achieved at Sol (rectified and integrated EMG activity
surface) for baseline control. Contractions had to be
maintained for at least 3 s and a minimum rest period of
20 s was allowed between each trial. Random FN stimula-
tions (2 × MT) were performed during these contractions
so that the stimulation occurred in about one out of three
contractions. The interval between the onset of Sol activa-
tion and the stimulation was also randomized. This ensured
that participants would not be able to predict during which
contraction the stimulation would be applied, or exactly
when it would occur after the onset of Sol activation. For
each leg tested, unconditioned and conditioned voluntary
EMG activity values for 10 FN stimulation trials were
recorded during Sol voluntary contractions [9].
Modulation data analysis
Assessments of the heteronymous modulation were all
performed off-line. For each trial, Sol EMG was full-
wave rectified from 100 ms before to 80 ms after FN
stimulation. Latency of changes in Sol EMG were expressed
in terms of zero central delay, i.e., when the fastest FN Ia
volley was expected to arrive at the segmental level of theghtly flexed (10°), the ankle slightly plantarflexed (110°) and the
ic plantarflexions. EMG activities at Sol (SOL EMG) and VL (VL EMG) were
n anode on the postero-lateral aspect of the buttock (FN stimulation).
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calculated for each participant based on latency Sol H reflex
and the difference in afferent conduction times between
homonymous and heteronymous Ia pathways for each leg
tested [29,43]. Early facilitation was found to peak within
6 ms after zero central delay in both healthy and stroke
participants tested in this study. Early facilitation reached
a maximal duration of 12 ms in healthy controls and
36 ms in some severely affected stroke participants. Later
inhibition can be observed in healthy participants as early
as 6 ms after zero central delay and can last up to 40 ms.
Thus, the level of facilitation for each participant was
measured by the surface of Sol EMG within the window
of analysis from 0 to 6 ms after the zero central delay
(about 25 to 31 ms after FN stimulation). The later modu-
lation was assessed within three, consecutive, 12-ms time
windows of analysis, from 12 to 24 ms, 24 to 36 ms and
36 to 48 ms after the zero central delay (about 37 to
73 ms after FN stimulation). Facilitation and inhibition
levels were measured at each time window during each
trial as the difference between the integrated rectified
EMG after the conditioning stimulation (conditioned
EMG) and before the stimulation (unconditioned EMG).
This difference was expressed as a percentage of the
control EMG measured within a 100-ms period of time
just before stimulation, and was then normalized for the
duration of the time windows of analysis for facilitation
(6 ms) and later modulation (12 ms) to allow comparisons
to be made. Mean modulation of Sol voluntary EMG was
assessed during ten isometric contraction trials, for each
leg tested [9].
Statistics
Mann-Whitney U and Wilcoxon tests were used during
the gait assessment to compare co-activation levels and
spatio-temporal characteristics of the gait cycle between
and within groups, respectively. Spearman rank correlations
were used to correlate clinical scores of coordination
(LEMOCOT), motor recovery (CMSA), spasticity (CSI)
and gait speed with levels of co-activation measured in
stroke individuals.
For the assessment of the heteronymous modulation,
an analysis of variance (ANOVA) comparison using
Scheffe’s method was performed to determine whether
or not there was significant facilitation and inhibition
throughout the assessment period before and after FN
stimulation. Mann-Whitney U and Wilcoxon tests were
used to compare levels of modulations between and
within groups, respectively. Pearson correlations were
used to correlate levels of co-activation with levels of
heteronymous modulation. P values ≤0.05 were consid-
ered significant. All statistical analyses were performed
using the Statistical Package for Social Science (SPSS)
software, version 19 for Windows.Results
Gait characteristics across participants
Spatio-temporal characteristics and co-activation levels
during gait were modified in stroke participants. Mean
EMG activities of VL, RF, Sol and RF during the gait cycle
(average of 9 strides) are presented for the paretic and
non-paretic legs of one stroke participant (# 4 in Table 1)
and for one leg of a healthy participant (see Figure 2). The
mean duration of the stance phase (DS1 + SS +DS2) on
the paretic side (mean of 9 strides ± SEM: 59 ± 0.4% of
the gait cycle) was shorter (P <0.01) than that on the
non-paretic side for the stroke participant (76 ± 0.4%),
and the control participant (69 ± 1.4%) (see Figure 2).
The peak activation interval between VLmax and Solmax
(PAI VL-Sol) on the paretic side (mean of 9 strides ± SEM:
12 ± 5% duration of the gait cycle) was shorter (P <0.05)
than the PAI VL-Sol on the non-paretic side for the stroke
participant (34 ± 3%) and the control participant (38 ± 1%)
(see left panel in Figure 2). The co-activation amplitude
index of Sol at the peak activation of VL (CAISol/Vlmax) (see
Θ in Figure 2) on the paretic side (mean of 9 strides ± SEM:
68 ± 5% of Sol EMG max) was higher than the CAISol/Vlmax
on the non-paretic side of stroke participants (44 ± 7%)
and higher than that in the control participants (18 ± 2%).
Similarly, the co-activation amplitude index of VL during
peak activation of Sol (CAIVL/Solmax) (see Ξ in Figure 2)
on the paretic side (69 ± 9% of VL EMG max) was not
significantly different from the value observed on the
non-paretic side (58 ± 3%) but was higher (P < 0.01) than
found in the control participants (22 ± 0.3%).
The peak activation interval between RFmax and GLmax
(PAIRF-GL) on the paretic side (8 ± 2% duration of the
gait cycle) of stroke participants was shorter (P <0.05)
than the PAI RF-GL on the non-paretic side (30 ± 4%) and
shorter than that observed in control participants (37 ± 1%)
(see right panel Figure 2). The co-activation amplitude
index of GL during peak activation of RF (CAIGL/RFmax)
(see ◊ in Figure 2) on the paretic side (88 ± 7% of GL EMG
max) was higher than the CAIGLRFmax on the non-paretic
side (23 ± 5%) and higher than that found among the
control participants (27 ± 3%). Similarly, the co-activation
amplitude index of RF when GL was at its peak activation
(CAIRF/GLmax) (see Δ in Figure 2) on the paretic side (75 ±
8% of RF EMG max) was significantly different (P <0.05)
from the value observed on the non-paretic side (6 ± 2%) as
well as that observed in the control participant (33 ± 1%).
Gait assessment across groups
Relative components of gait cycle sub-phases were modi-
fied on the paretic side of stroke participants (see Figure 3).
The mean duration of the stance phase (DS1 + SS + DS2)
on the paretic side (mean ± SD: 65 ± 4% of the duration of
the gait cycle) was shorter (P < 0.05) than the duration on
the non-paretic side of stroke participants (76 ± 6%) and
Figure 2 Mean rectified EMG of vastus lateralis, soleus, rectus femoris and gastrocnemius lateralis during gait in a stroke participant and a
healthy participant. Tracing of averaged rectified EMG activities of knee extensors (continuous line) and ankle extensors (dotted line) are
presented for the paretic (upper panel) and non-paretic (middle panel) sides of a stroke participant (# 4 in Table 1) and a healthy participant
(lower panel) walking at 0.99 m/s and 1.04 m/s, respectively. Tracing are averaged for 9 cycles, expressed as a percentage of maximal EMG. The
duration (length of time) of the first double-support (DS1), single-support (SS), second double-support (DS2) sub-phases of stance and of the
swing phase (SW) are presented in relation to the entire gait cycle. Co-activation of vastus lateralis (VL) and soleus (Sol) is presented in the left
panel. Co-activation of rectus femoris (RF) and gastrocnemius lateralis (GL) is presented in the right panel. Arrows represent the latencies in
maximal activation of vastus lateralis (VLmax), soleus (Solmax) rectus femoris (RFmax) and gastrocnemius lateralis (GLmax). Circles represent the
amplitude of the soleus co-activation index during peak activation of VL (CAISol/Vlmax). Squares represent the amplitude of vastus lateralis
co-activation during peak activation of Sol (CAIVL/Solmax). Lozenges represent the amplitude of gastrocnemius lateralis co-activation
during peak activation of RF (CAI GL/RFmax). Triangles represent the amplitude of rectus femoris co-activation during peak activation of GL
(CAI RF/GLmax).
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Figure 3).
Timing of peak activation of ankle extensors was
modified in the paretic leg of stroke participants (see
Figure 4). The same was not true for knee extensors. Mean
latencies in peak activation of VL and RF on the paretic
side were not significantly different from the values onthe non-paretic side in stroke participants and in control
participants. The mean latency in peak activation of GL
on the paretic side was shorter (P < 0.05) than that on the
non-paretic side and that in control participants. The
latency in peak activation of Sol on the paretic side was
not significantly different from that on the non-paretic
but was shorter in control participants. Moreover, peak
Figure 3 Group comparisons of gait cycles in 13 stroke and 10 healthy participants. The mean duration of gait cycle phases are presented
for the paretic (upper bar) and non-paretic (middle bar) sides of stroke participants and for control participants (lower bar). Percentages of first
double-support (DS1), single-support (SS), second double-support (DS2) sub-phases of the stance phase and of the swing phase (SW) are expressed as
a percentage of the duration of the gait cycle. The schematic representation of the position of the lower limbs during each phase is presented
with the black leg being the one assessed. Arrows represent the mean latencies in the peak activation of vastus lateralis (VL), rectus femoris
(RF), gastrocnemius lateralis (GL) and soleus (Sol) during the gait cycle.
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paretic side of stroke individuals were not different from
the values observed in control participants.
Co-activation of knee and ankle extensors during the
stance phase in stroke participants was higher than in
control participants (see Figure 5). Mean peak activation
intervals (PAI) between knee and ankle extensors on
the paretic side of stroke participants were shorter than
the PAIs in the control participants but were not sig-
nificantly different from the values on the non-paretic
side. Co-activation amplitude indexes (CAI) of knee
extensors during peak activation of ankle extensors
were significantly higher on the paretic side of stroke
participants than the CAI of knee extensors in control
participants, except for the level of VL activation at
GLmax (CAIVL/Glmax). These CAIs were not significantly
different between the paretic and non-paretic side. All
ankle extensor CAIs during peak activation of knee
extensors measured on the paretic and non-paretic sides of
stroke participants were greater than the values recorded
for control participants.
PAI VL-Sol correlated with levels of spasticity (CSI:
Spearman r = -0.65; P =0.016) and motor impairment
(CMSA: r =0.55; P =0.05) of the paretic leg. CAIVL/Solmax
correlated with levels of spasticity (CSI: r =0.66; P =0.015),
motor impairment (CMSA: r = -0.66; P =0.014) and
coordination (LEMOCOT: r = -0.69; P =0.009). CAIsof ankle extensors during maximal quadriceps activation
did not correlate with clinical measures.
Heteronymous modulation across participants
An increase in early facilitation and a decrease in the later
inhibition of Sol voluntary EMG induced by FN stimula-
tion was observed in the paretic leg of stroke participants.
The heteronymous modulation of Sol EMG is presented
in stroke participants with severely (participant #10 in
Table 1) and mildly (participant # 11 in Table 1) impaired
coordination (LEMOCOT score: 13 and 52, respectively)
and in a control participant (see Figure 6). In the first time
window of analysis from 0 to 6 ms after zero central delay,
early facilitation of the severely affected stroke participant
(mean ± SEM; increase of 397 ± 24% of Sol control EMG
surface) was higher (P <0.01) than facilitation in the
slightly impaired participant (218 ± 7%) and in the control
participant (76 ± 6%). From 12 to 24 ms after the zero
central delay, the facilitative modulation observed in the
severely impaired participant (157 ± 15%) was higher than
(P <0.05) the modulation observed in the mildly impaired
stroke participant (16 ± 7%) and significantly different
(P < 0.001) from the inhibition (decrease of 51 ± 4% of Sol
control EMG surface) observed in the control participant.
In the next time window from 24 to 36 ms, the facilitation
observed in the severely impaired participant (increase of
30 ± 9%) was significantly different (P <0.05) from the
Figure 4 Group comparisons of peak activation latencies for vastus lateralis, rectus femoris, gastrocnemius lateralis and soleus during
gait in 13 stroke and 10 healthy participants. Peak activation latencies for vastus lateralis (VL), rectus femoris (RF), gastrocnemius lateralis (GL)
and soleus (Sol) during the stance phase of gait are expressed as a percentage of the gait cycle. Mean peak activation latencies are presented for
the paretic (black bars) and non-paretic (grey bars) sides of stroke participants and control participants (white bars). Vertical bars =1 SEM. Asterisks
represent significant differences between groups (* p ≤0.05).
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pant (decrease of 27 ± 4%) and significantly different
from the inhibition (decrease of 59 ± 1%) observed in
the control participant.
Heteronymous modulation across groups
The mean heteronymous modulation of Sol voluntary
EMG induced by FN stimulation observed in the stroke
group was different from that of the control group (see
Figure 7). The early facilitation (from 0 to 6 ms after the
zero of central delay) observed in the stroke group was
greater than the facilitation in the control group. In the
next three time windows, the modulation observed in
the stroke group was different (P <0.01) compared with
the inhibition observed in the control group.
Correlations between co-activations and heteronymous
modulations
Correlations were found between co-activation indexes
and changes in heteronymous modulations in stroke par-
ticipants but not in healthy participants. Table 2 presents
the correlations found between co-activation indexes
assessed during gait and the heteronymous modulation ofSol measured during the four consecutive time windows
of analysis after FN stimulation in both groups. The peak
activation interval between VL and ankle extensors
(PAIVL-Sol and PAIVL-GL) and the level of co-activation of
VL during peak activation of Sol (CAIVL/Solmax) correlated
with the heteronymous modulation within the first time
window from 0 to 6 ms after the zero central delay in
stroke participants. The PAIVL-Sol was consistent with the
modulation within the subsequent time window from
12 to 24 ms. PAIVL-GL correlated with the modulation
from 24 to 36 ms. No significant correlations were found
between the co-activation indexes and heteronymous
modulations in the control participants.
Discussion
Changes in gait cycle and muscle co-activation after stroke
Our results show an increased co-activation of knee and
ankle extensors in hemiparetic gait compared to healthy
participants. The peak activation interval (PAI) and co-
activation amplitude index (CAI) measures used in the
present study were sensitive enough to detect abnormal
levels of EMG co-activation of leg extensors during gait
in the paretic and non-paretic legs of stroke individuals.
Figure 5 Group comparisons of co-activation indexes in 13 stroke
and 10 healthy participants. Mean peak activation intervals (PAI) and
co-activation amplitude indexes (CAI) measured during the stance phase
are presented for the paretic (black bars) and non-paretic (grey bars)
sides of stroke participants and for control participants (white bars). PAIs
between knee extensors (vastus lateralis: VL or rectus femoris: RF) and
ankle extensors (soleus: Sol and gastrocnemius lateralis: GL) are expressed
as a percentage of the gait cycle duration (upper panel). CAI of knee
extensors (VL and RF), expressed as a percentage of their maximal EMG
activation during peak activation of ankle extensors (at Solmax and GLmax),
are also presented (middle panel). CAI of ankle extensors (Sol and GL),
expressed as a percentage of their maximal EMG activation, during peak
activation of knee extensors (at VLmax and RFmax) are presented (lower
panel). Vertical bars =1 SEM. Asterisks represent significant differences
between groups (* p ≤0.05; ** p ≤0.01; *** p ≤0.001).
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extensors on the paretic side during static contractions.
Abnormal torque coupling between hip adduction and
knee extension has been reported during submaximal
static contractions while standing with the leg positioned
in the toe-off position of gait [44]. An abnormal increase in
co-activation of hip and knee extensors has been reported
during maximal isometric hip and knee extensions on
the paretic side while standing [45]. Shared patterns of
activation among different muscle groups have been
identified in the paretic lower limb during gait using
EMG data analyses based on factorization procedures
[19,20]. Accordingly, a shared pattern of activation was
observed between ankle extensors and knee extensors
(RF and VM) throughout the stance phase of the paretic
leg but not among controls [20].
All PAIs measured in the present study were at least
two times shorter on the paretic side compared to those
measured in the control group. PAI values on the non-
paretic side also tended to be shorter than the values
recorded for control participants. Lower PAI values are
essentially attributable to the earlier activation and rapid
increase in ankle extensor activity which leads to increased
temporal co-activation of leg extensors in hemiparetic gait.
CAI values in stroke participants were also twice higher
than values in healthy participants. This is consistent with a
study on standing position that showed co-activation of
knee and ankle extensors during maximal static ankle and
knee extensions on the paretic side, with recorded values
twice those of the healthy controls [2]. Furthermore, the
amplitude of the co-activation measured during gait in the
present study was higher than the levels measured in a
standing position under static conditions in stroke and
healthy participants [2]. This suggests that the co-activation
of leg extensors on the paretic side might be higher during
a dynamic task such as gait than during a static task.
It is important to consider that the co-activation mea-
sures used in the present study are not independent. In
fact, a reduction in the peak activation interval (PAI)
should coincide with an increase in co-activation amplitude
index (CAI). Both measures of co-activation used in the
present study were closely related to the timing of knee and
ankle extensor activation during the gait cycle. This timing
is essentially measured by the PAI. However, the PAI
does not take into account the relative variation in EMG
amplitude during the gait cycle. Such modulation of EMG
amplitude throughout the gait cycle can also be referred
as the shape of the EMG profile for each muscle. The aim
of the present study was to compare the co-activation of
knee and ankle extensors between stroke and control
participants. Therefore, one should consider potential
differences in the shape of the EMG tracings of knee and
ankle extensors between stroke and control participants.
Some characteristics of the EMG recordings, such as the
Figure 6 Effects of femoral nerve stimulation on voluntary soleus
EMG activity in two stroke participants and one control participant.
Tracings of averaged rectified EMG activities of ten trials are presented
for the paretic sides of stroke participants with severely (A) or slightly
(B) impaired coordination and for the right leg of a control participant
(C). Arrows indicate the zero central delay, which is the expected time
of arrival of the fastest FN Ia volley at the segmental level of the soleus
motoneuron (Mn) pool. The latency scale is presented from 20 ms to
80 ms after FN stimulation (lower scale) and from 0 to 36 ms after the
zero central delay (upper scale). Horizontal lines represent the mean
amplitude of the unconditioned EMG activity (baseline EMG level).
Facilitation was assessed within the time window from 0 to 6 ms after
the zero central delay. Asterisks represent significant modulations of
soleus within three time windows of analysis from 0 to 6 ms, 12 to
24 ms and 24 to 36 ms after the zero central delay (* p ≤0.05;
** p ≤0.01; *** p ≤0.001).
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and the EMG ascending time to reach peak activation, are
expected to be different in stroke and control participants.
In this respect, CAI provides complementary information
based on PAI since CAI measure takes into account
the relative EMG amplitude of the muscle at a specific
moment within the gait cycle. This may explain why
co-activation differences between the non-paretic leg of
stroke participants and the tested leg in controls have been
found with CAI measures but not with PAI measures.
Future studies should investigate whether PAI and CAI
correlate with measures of co-activation based on more
complex mathematical analyses of EMG signals such as
factorization analyses.
One limitation of the present study is that only knee
and ankle extensors have been assessed. Therefore, this
study did not determine whether knee and ankle extensors
co-activate with other muscles or whether co-activations
of other muscles are greater than that of knee and ankle
extensors. Stroke can lead to reduced control of many
lower limb muscles during gait. Earlier activation of ankle
extensors in hemiparetic gait might be triggered by their
co-activation with muscles other than the knee extensors
which are activated during mid-stance. The present study
focused specifically on the assessment of knee and ankle
extensors in an attempt to quantify the pathological exten-
sor synergy often described in hemiparetic gait.
Possible mechanisms behind inter-joint co-activation
The mechanisms underlying global synergistic activation
of the leg extensor muscles when stroke patients attempt to
move the paretic leg are not fully understood. Weakness,
changes in motor unit recruitment, changes in supraspinal
influences and dysfunction of spinal pathways have been
suggested as possible mechanisms involved in abnormal
synergistic co-activations after stroke [9,46]. In terms of
weakness, some evidence suggests that abnormal inter-joint
co-activation is an adaptive strategy to compensate for
unequal distribution of weakness across joints and muscles
Figure 7 Effects of femoral nerve stimulation on soleus voluntary EMG activity in 13 stroke and 10 healthy participants. Mean
modulation of soleus voluntary EMG activity induced by FN stimulation for the stroke group (black squares) and the control group (white
squares) expressed as a percentage of unconditioned EMG. Modulations are presented within the four time windows from 0 to 6 ms, 12 to
24 ms, 24 to 36 ms and 36 to 48 ms after the zero of central delay. Positive values (i.e., above zero on the ordinate scale) are facilitation and
negative values are inhibition. Vertical bars =1 SEM. Asterisks represent significant differences in modulation between the control and stroke
participants (* p ≤0.05; ** p ≤0.01; *** p ≤0.001).
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that the presence of co-activation may impede torque
generation and contribute to weakness rather than it being
the result of lost strength in the paretic leg [45,47]. The
inability to adequately recruit motor units, albeit more as-
sociated with weakness, could indirectly contribute to the
presence of co-activation in the paretic limb. A reduction
in the frequency of motoneurone discharges and in the
number of motor units available [48-50] could play a role
in limited movement repertoire and therefore synergistic
co-activation in hemiparesis.Table 2 Correlation coefficients (Pearson) between heteronym
co-activation indexes during gait
Group Modulation
Time window (ms after ZCD) PAIVL-Sol PAIVL-GL PAIRF-Sol P
Stroke (0-6) -0.73** -0.62* -0.41
(12-24) -0.65* -0.45 -0.24
(24-36) -0.550 -0.62* -0.27
(36-48) -0.21 -0.40 -0.14
Control (0-6) -0.40 -0.55 -0.29
(12-24) -0.04 -0.33 -0.45
(24-36) -0.24 -0.11 -0.28
(36-48) -0.10 -0.11 -0.12
PAI: peak activation interval; CAI: co-activation amplitude index; Sol: soleus; GL: gas
central delay; Significant correlations are in bold; *p ≤ 0.05; **p ≤ 0.01.Changes in supraspinal influences could affect the ability
to activate muscles selectively. For example, the neural
reorganization resulting from stroke is associated with
an enlargement of the cortical areas activated during
voluntary tasks that could contribute to abnormal syn-
ergistic recruitment [51-53]. The interruption of direct
corticospinal drive could enhance the influence of other
indirect (i.e., reticulo- and vestibulospinal) pathways that
produce less specific motor recruitment and lead to syner-
gistic muscular activation in hemiparesis [46,52]. Finally,
changes in supraspinal influences due to stroke mayous modulations produced by FN stimulation and
Co-activation indexes
AIRF-GL CAIVL/at Solmax CAISol/at VLmax CAIRF/at GLmax CAIGL/at RFmax
-0.34 0.57* -0.32 -0.44 -0.47
-0.09 -0.43 -0.23 -0.22 -0.24
-0.35 -0.49 -0.17 -0.26 -0.38
-0.32 -0.29 -0.01 -0.08 -0.22
-0.24 -0.14 -0.33 -0.16 -0.29
-0.55 -0.10 -0.28 -0.14 -0.25
–0.14- -0.05 -0.33 -0.16 -0.16
-0.03 -0.10 -0.11 -0.13 -0.11
trocnemius lateralis; VL: vastus lateralis and RF: rectus femoris; ZCD: zero
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muscular coordination [54].
Changes in heteronymous modulation after stroke
An increase in early heteronymous facilitation and a
decrease in later inhibition of Sol voluntary EMG after
FN stimulation were observed in the paretic leg of stroke
individuals. Previous findings showed similar changes in
heteronymous modulation using Sol H reflex [21]. Thus,
changes in the excitability of propriospinal interneuronal
pathways which integrate peripheral afferents do not only
affect the reflex activity of motoneurones but also the
activity triggered by descending voluntary drive. Early
heteronymous facilitation and later inhibition are thought
to be mediated by intersegmental group Ia afferents
excitation and recurrent inhibition projecting from FN
to Sol MNs, respectively, and moving through short
propriospinal pathways [28,29,43,55,56]. Several spinal
mechanism impairments have been reported after stroke
and could contribute to modifications in heteronymous
modulation. A reduction in presynaptic inhibition of
group Ia terminals [57], a decrease in post-activation de-
pression [22], an increase in group I and II intersegmental
excitatory influences [58,59] and changes in recurrent in-
hibition [60] are among the mechanisms that could po-
tentially increase heteronymous facilitation and thus
decrease later inhibition. Moreover, an increase in group
II intersegmental excitatory influences has been reported
during early stance in the gait cycle on the paretic side in
stroke patients [61].
Correlations between co-activation and heteronymous
modulation
Some co-activation indexes correlated with the modified
heteronymous modulations in the paretic leg. This dem-
onstrates that the stroke patients who presented the
highest levels of co-activations were also those who
showed the highest levels of heteronymous facilitation.
Although these correlations do not establish a causal
relationship between the abnormal simultaneous activation
of knee and ankle extensors during stance and changes in
the heteronymous modulation, this finding opens the way
for future studies to explore whether such a relationship
exists. Most correlations were between reduced peak
activation intervals and the impaired modulation. This
raises the question as to whether changes in transmission
of intersegmental pathways might contribute to reduce
the activation delay between knee and ankle extensors
during early stance. Changes in heteronymous pathways
could theoretically contribute to co-activation of leg ex-
tensors in the paretic leg during the stance phase. This
hypothesis is supported by the fact that the delay in
intersegmental influence of Quads afferents on Sol
motonoreures is short enough to affect the activity ofankle extensors in early stance. The central delay of the
heteronymous modulation of Sol is only of 22 ms after FN
stimulation and can last up to 40 ms in healthy subjects.
In stroke participants, changes in the heteronymous
modulation can be observed for up to 50 ms after the
zero of central delay. Since EMG activity of knee and
ankle extensors can overlap for 200 ms in the early stance
phase [62], the facilitative heteronymous influence of the
Quads has enough time to influence ankle extensors in
this phase. The shortening of peak activation intervals
in stroke patients is primarily due to early calf muscle
activation, as opposed to changes in quadriceps activation
timing [7]. One can therefore hypothesize that, in severely
affected stroke individuals, activation of knee extensors
at high levels at the beginning of the stance phase can
produce an overall facilitative intersegmental influence
on plantarflexors, which could contribute to triggering
co-activation earlier during the mid-stance phase. Some
evidence shows that the heteronymous modulation linking
Quads and Sol is regulated according to postural tasks
and gait phases [43,63]. Changes in the regulation of this
heteronymous modulation could be involved in coordin-
ation changes in these muscles in hemiparetic gait. Such
changes in the regulation of heteronymous pathways
during gait have been found in stroke patients [61,64,65]
and might contribute to their functional deficits.
With respect to CAI, only the VL amplitude at Sol max
significantly correlated with the heteronymous modulation.
This might suggest that: 1) the intersegmental pathways
assessed in the present study might be more relevant to the
timing between knee and ankle extensors rather than the
modulation of the intensity of co-activation, or 2) the
effects of the quadriceps afferents on calf muscle EMG
amplitude take time to build up and are seen after the
quadriceps reach their maximal activation. Intersegmental
influences occur between many muscles and some may be
stronger than others. It is possible that the influences from
calf muscles, when these muscles are stretched during
eccentric contraction during mid-stance, could modulate
the intensity of quadriceps activation in hemiparetic
gait. Such modulation would involve other propriospinal
pathways than those assessed in the present study. Interseg-
mental pathways projecting from Sol to Quads have been
found in healthy humans [66,67]. There are excitatory Ia
afferents and recurrent inhibition influences [66,67] but
also facilitation from group II afferents projecting from Sol
to Quads MNs [68]. Future studies should investigate
whether potential changes in these other pathways could
be related to increased amplitude of co-activation of knee
extensors while plantarflexors are voluntarily activated in
the paretic leg.
It is important to keep in mind that the correlations
between co-activations and changes in heteronymous
modulations found in the present study are not sufficient
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mal co-activation and the impairment of intersegmental
mechanisms. In fact, several supraspinal and other spinal
mechanisms can be affected by a stroke and contribute to
the abnormal co-activation of knee and ankle extensors
in hemiparetic gait. Abnormal co-activation and changes
in intersegmental pathways observed in the present study
might each be related to the extent of neurologic impair-
ment after stroke, rather than being linked by a causal
relationship. Moreover, some limitations of the study
restrict the interpretation of the correlations between
co-activation and heteronymous modulations. These
limitations are related to the different conditions under
which the assessments were performed. Heteronymous
modulation was assessed under a static condition while
participants were seated, whereas co-activation was as-
sessed under a dynamic condition during gait. Although
the conditions of assessment were different, correlations
were found between the heteronymous modulation and
co-activations, thereby suggesting a co-relationship be-
tween these measures. It can be hypothesized that the
correlations found between the results of these assess-
ments would have been greater had these assessments
been performed under similar conditions. Future stud-
ies should investigate to what extent intersegmental
pathways are modified during gait and whether changes
in these pathways contribute to motor deficits observed
in hemiparetic gait.
Functional considerations
Our results showed that PAIVL-Sol was correlated with
levels of spasticity and motor impairment of the paretic
leg. Furthermore, the level of co-activation of VL during
peak activation of Sol (CAIVL/Solmax) was correlated with
the levels of spasticity, motor impairment, and coordination
of the paretic leg. It has been suggested that spasticity may
account for early activation of calf muscles while these
muscles are being stretched during the stance phase given
the load on the limb [14]. This premature activation causes
co-activation to occur because the quadriceps muscle is
contracting. Results also suggest that the greater the
amplitude of co-activation, the more uncoordinated the
stroke subject is.
The correlation between co-activation indexes and motor
impairment levels suggests that co-activation between VL
and Sol could be either an adaptation (i.e., compensation)
or a consequence of motor deficits of the paretic leg. It has
been shown that deficits of selective muscular activation
due to neurological impairment may be associated with
global co-activation of knee and ankle extensors when
severely affected stroke patients attempt to control weight
bearing on the paretic leg during gait [8,14,69,70]. Prema-
ture activation of ankle extensors during mid-stance
may contribute to body weight support and compensatefor knee extensor weakness in the stroke population.
Activation of RF during mid-stance could also be an
adaptation method to compensate for the lack of exten-
sion with the paretic leg and thus contribute to body
weight support. Thus, increased co-activation of mus-
cles acting at different joints could be a strategy to
compensate for weakness at single joints. Such a strat-
egy could be relevant to hemiparetic gait efficiency
since strength measures at the hip [71,72], knee [73,74]
and the ankle [75,76] have been associated with gait
performance after stroke.
Few studies have related abnormal co-activation with
motor deficits after stroke. Co-activation of antagonist
muscles at the ankle and synergistic co-activation of hip
and knee extensors during alternate flexion and extension
of the paretic leg in a supine position have been correlated
with the level of motor impairment and gait performance
[77]. It is still not clear whether abnormal synergistic
co-activation observed during gait contributes to gait defi-
cits or is an adaptation to compensate for these deficits.
For example, inappropriate co-activation of leg flexors,
including ankle dorsiflexors, could hamper propulsion
provided by weak plantarflexors during stance [78] but
assist with forward progression of the limb during the
swing phase [77]. Similarly, co-activation of leg extensors
could impede gait during the swing phase but contribute
to weight bearing during the stance phase [77]. However,
in the present study, no correlation was found between
co-activation levels and walking performance measured
by gait speed, despite variations from 0.5 to 1.3 m/s.
This is consistent with some evidence demonstrating
that improvement in gait speed is neither related to a
reduction of abnormal co-activation patterns nor to a
reduction in agonist-antagonists co-activation [79,80].
Other factors, particularly adaptations of the other leg,
must be considered when evaluating gait performance
and gait speed after stroke.
Results of the present study have shown significant
changes in the non-paretic leg. Hemiparetic participants
spent more time in stance on the non-paretic leg com-
pared to the paretic leg. The reduced percentage of time
spent in stance on the paretic leg may be the consequence
of weakness that prevents optimal weight acceptance on
the affected side [81]. Gait speed is positively correlated
with the percentage of time spent in the stance phase on
the non-paretic side but not on the paretic side among
stroke patients [81]. This suggests that changes in the
percentage of time spent in stance and swing with the
non-paretic leg may be relevant to hemiparetic gait as
potential adaptations to compensate for motor deficits
of the paretic leg. Evidence suggests that compensatory
strategies of the non-paretic leg could be even more
important than those of the paretic leg in hemiparetic
gait performance [80].
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This study has quantified increased co-activation of knee
and ankle extensors during the stance phase of gait in
stroke individuals. PAI and CAI have been used to compare
levels of temporal and relative amplitude of co-activation
between stroke and healthy participants, respectively.
Changes were identified with both co-activation indices
after stroke. Moreover, temporal co-activation indexes
correlated with changes in heteronymous modulations of
soleus activity induced by femoral nerve stimulation. These
results suggest that transmission changes in intersegmental
pathways linking quadriceps to soleus could contribute to
the timing of abnormal co-activation of knee and ankle
extensors in hemiparetic gait. Further studies should inves-
tigate other propriospinal pathways, examine the extent to
which co-activation of leg extensors on both the paretic
and non-paretic side of stroke patients adapt to com-
pensate for motor deficits, and determine whether this
co-activation is the result of neurological impairments.
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